Rosangela Lattanzio
@hsr.it
Scopus Publications
- Scan Density Matters: Reproducibility of AI-Derived OCT Biomarkers in Diabetic Macular Edema
Massimiliano Cocuzza, Makan Ziafati, Rosangela Lattanzio, Edoardo Midena, Francesco Bandello, Maria Vittoria Cicinelli, for the Current Research Directions in Ophthalmology Working Group
Translational Vision Science and Technology, 2026
Purpose: To determine how optical coherence tomography (OCT) scan density affects quantification of artificial intelligence (AI)-derived structural biomarkers in diabetic macular edema (DME) and to identify density thresholds beyond which biomarker fidelity is compromised. Methods: In this cross-sectional study, 401 DME eyes underwent three same-session OCT acquisitions using 97-, 49-, and 25-B-scan raster protocols on a single device. A CE-certified deep learning pipeline quantified intraretinal fluid (IRF) volume, subretinal fluid (SRF) volume, inflammatory hyperreflective foci (I-HRF), and photoreceptor integrity metrics. Linear mixed-effects models assessed density effects, Bland-Altman analyses quantified fixed and proportional bias, and volumetric thresholds were computed for deviations beyond ±0.10 mm³. Acquisition efficiency integrated biomarker variability and scan time. Results: A total of 9624 biomarker measurements were analyzed with >98% completeness. SRF volume, I-HRF counts, and photoreceptor integrity metrics were stable across scan densities. IRF volume was density-dependent: the 25-scan protocol overestimated IRF relative to 97- and 49-scan acquisitions (mean bias -0.077 and -0.079 mm³; both P < 0.001), whereas 97- and 49-scan measurements were interchangeable. Overestimation increased with fluid burden (IRF threshold ∼1.1 mm³). Although the 25-scan protocol was fastest (10.7 seconds vs. 23.6 seconds and 50.3 seconds), the 49-scan protocol provided the best balance between speed and precision. Conclusions: Most AI-derived OCT biomarkers in DME are robust to reduced scan density, but IRF volume shows increasing error with undersampling. Higher-density scans should be reserved when precise fluid quantification is required. Translational Relevance: Scan density materially influences AI-derived IRF quantification. Identifying practical acquisition thresholds enables protocol standardization while reducing imaging burden in clinical practice and trials. - What Lies beneath Diabetic Macular Edema: Latent Phenotypic Clustering and Differential Treatment Responses to Intravitreal Therapies
Maria Vittoria Cicinelli, Beatrice Leonardo, Giacomo Maiucci, Giuliano Martino, Makan Ziafati, Soufiane Bousyf, Luisa Frizziero, Rosangela Lattanzio, Edoardo Midena, Francesco Bandello
Ophthalmology Science, 2026
Purpose: To identify latent phenotypic subgroups of diabetic macular edema (DME) using artificial intelligence-based OCT metrics and evaluate whether treatment responses to anti-VEGF and dexamethasone (DEX) therapies differ across these phenotypic clusters. Methods: Retrospective study including 114 eyes (82 patients) with treatment-naïve DME. Quantitative OCT metrics, including intraretinal fluid (IRF) and subretinal fluid volumes, IRF % distribution within central 0-1, 1-3, and 3-6 mm, hyperreflective foci counts, and ellipsoid zone (EZ) % disruption, were analyzed before and after treatment. Main Outcome Measures: Gaussian finite mixture modeling was used to identify distinct DME subgroups. Changes in visual acuity (VA) and OCT parameters following anti-VEGF or DEX therapy were analyzed using linear and generalized linear mixed-effects models, with false discovery rate correction applied to account for multiple comparisons. Results: ), significant structural disruption (EZ disruption: 46%), and the poorest VA (mean LogMAR: 0.63); and cluster 3 (22%, 95% CI: 13.9%-31.2%), showing intermediate fluid levels and minimal structural damage (EZ disruption: 0.5%). Anti-VEGF therapy led to the greatest VA improvement in cluster 2 (-31.5%, standard deviation: 28.6). Pairwise contrasts showed no significant VA differences between DEX and anti-VEGF in cluster 1 (-26.6%, 95% CI: -64.7 to 11.6) or in cluster 3 (-12.4%, 95% CI: -58.2 to 33.4), although the direction of effect suggested a trend toward greater improvement with DEX. In contrast, cluster 2 showed a nonsignificant difference favoring anti-VEGF (+25.0%, 95% CI: -4.6 to 54.6). For central subfield thickness, DEX achieved a significantly greater reduction than anti-VEGF in cluster 3 (-20.9%, 95% CI: -37.0 to -4.9) and was also associated with a relative increase in peripheral IRF distribution in cluster 3 (+26.7%, 95% CI: 6.5 to 46.9), supporting phenotype-dependent treatment effects. Conclusions: Latent heterogeneity in DME presentations may influence treatment responses. Artificial intelligence-derived spectral-domain OCT metrics could support tailored therapeutic approaches to optimize patient outcomes. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article. - Macular Edema Resistance in Retinal Vein Occlusion and the Protective Role of PAMM Subtypes
MARIA VITTORIA CICINELLI, ENRICO MARIA PEPE, BEATRICE TOMBOLINI, MARCO ROMANELLI, STEFANO ALBERTINI, MARIA PIA DECARLO, SEBASTIANO DEL FABBRO, CHIARA GIUFFRÉ, FRANCESCO BANDELLO, ROSANGELA LATTANZIO
American Journal of Ophthalmology, 2026 - Risk Analysis of Retinal Hemangioblastomas in Nonadvanced Stages of von Hippel–Lindau Syndrome Using Ultra-widefield Imaging: The ULTRA von Hippel–Lindau Study
Sebastiano Del Fabbro, Maria Vittoria Cicinelli, Rosangela Lattanzio, Soufiane Bousyf, Lorenza Bruno, et al.
Ophthalmology Science, 2025
<h2>ABSTRACT</h2><h3>Purpose</h3> To investigate the longitudinal progression, risk factors, and complications associated with retinal hemangioblastomas (RHs) in non-advanced stages of von Hippel-Lindau (VHL) syndrome using ultra-widefield (UWF) imaging. <h3>Design</h3> Single-center, longitudinal cohort study. <h3>Subjects</h3> Caucasian patients with genetically confirmed VHL syndrome. <h3>Methods</h3> Annual evaluations included dilated fundus examinations, UWF pseudocolor fundus retinal images, UWF fluorescein angiography, and optical coherence tomography. Genetic analysis classified VHL mutations. Baseline RH counts and anatomical distributions were recorded as central (juxtapapillary, macular), peripheral, or both. Longitudinal follow-up tracked new RH formation and visual acuity values. <h3>Main Outcome Measures</h3> Cumulative incidence, incidence rate ratios (IRRs), and risk factors of new RHs assessed using mixed-effects negative binomial regression models. Hazard of recurrent RHs evaluated through Cox frailty models, and longitudinal changes in visual acuity. <h3>Results</h3> Among 78 eyes of 43 patients (mean age: 47.8±13.6 years), 110 RHs were documented at baseline, with 3 (3%) centrally located, 35 (32%) peripherally, and 72 (65%) spanning both zones. VHL variants were investigated in 37 patients: 19 had missense variants (51%) and 18 had presumed null alleles (49%), including nonsense (10/37, 27%), frameshift (1/37, 3%), splice-site (1/37, 3%), and exon deletion mutations (6/37, 16%). Over a median follow-up of 31 months (IQR: 27–109), 35 (43%) eyes developed new RHs, with an incidence rate of 0.22 RHs per eye-year (95% CI: 0.17–0.27). By the last available examination, 26 eyes (34%) remained disease-free, while 17 (23%) showed no progression of existing RHs. Age reduced the IRR of new RHs by 4.2% annually (p=0.003), while higher baseline tumor burden and vascular leakage increased the IRR significantly (p<0.001 and p=0.03, respectively). Peripheral RHs were the strongest predictor of recurrence (HR=16.4, p<0.001), while older age remained protective (HR=0.96, p=0.04). Visual acuity (logMAR) worsened from 0.05±0.2 (Snellen equivalent: 20/22) at baseline to 0.11±0.3 (Snellen equivalent: 20/25) at the final visit. <h3>Conclusion</h3> Peripheral RHs and vascular leakage are significant risk factors for RH progression and recurrence in VHL syndrome. While older age provides a protective effect, close monitoring of high-risk eyes is essential to enable timely intervention and preserve vision. - AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
Edoardo Midena, Marco Lupidi, Lisa Toto, Giuseppe Covello, Daniele Veritti, Elisabetta Pilotto, Maria Vittoria Cicinelli, Rosangela Lattanzio, Michele Figus, Giulia Midena, Luca Danieli, Enrico Borrelli, Michele Reibaldi, Daniele Tognetto, Leandro Inferrera, Simone Donati, Settimio Rossi, Paolo Melillo, Paolo Lanzetta, Valentina Sarao, Giulia Gregori, Carlo Cagini, Chiara Maria Eandi, Adriano Carnevali, Vincenzo Scorcia, Emilia Maggio, Grazia Pertile, Ciro Costagliola, Gilda Cennamo, Paolo Mora, Roberto Dell’Omo, Marzia Affatato, Marzia Passamonti, Mariacristina Parravano, Nicola Vito Lassandro, Marco Nassisi, Francesco Viola, Niccolò Castellino, Francesco Cappellani, Giuseppe Giannaccare, Francesco Boscia, Maria Oliva Grassi, Donatella Musetti, Valentina Folegani, Alessandro Invernizzi, Luca Rossetti, Tommaso Bacci, Federico Ricci, Marco Lombardo, Mary Romano, Nicola Valsecchi, Michele Coppola, Fabiano Cavarzeran, Luisa Frizziero
Journal of Clinical Medicine, 2025
Purpose: To characterize, using clustering analysis, the OCT morphological and clinical phenotypes of diabetic macular edema (DME) in a very large population (>2000 DME eyes) using standardized and validated OCT-based biomarkers. Methods: A cross-sectional study was conducted on OCT scans collected from 2355 eyes of 1688 patients with DME and performed during real-world clinical practice. OCT scans were automatically analyzed by a software able to automatically quantify OCT key biomarkers: intraretinal fluid (IRF), subretinal fluid (SRF), hyperreflective retinal foci (I-HRF), and external limiting membrane (ELM) and ellipsoid zone (EZ) interruption. Clustering analysis was performed using the above-mentioned biomarkers, including the distribution of IRF across the three ETDRS rings. Results: The overall population was predominantly composed of type 2 diabetes patients (89%), with a mean diabetes duration of 15.6 ± 10.7 years and mean best corrected visual acuity (BCVA) of 63 ± 18 ETDRS letters. Multivariate clustering identified four morphological phenotypes with distinct patterns of fluid distribution associated with different I-HRF counts, SRF volume, and percentages of ELM/EZ integrity (p < 0.0001). Conclusions: This large OCT analysis identified distinct morphological subtypes of DME, confirming the clinical relevance of key imaging biomarkers. The distribution and severity of DME features differ among clusters, supporting the importance of OCT-based phenotyping in tailoring treatment strategies and understanding disease evolution. - Central Bouquet Hemorrhages in Retinal Vein Occlusion: A Distinct Pathway to Macular Atrophy
Maria Vittoria Cicinelli, Enrico Maria Pepe, Prithvi Ramtohul, Beatrice Tombolini, Stefano Puligheddu, Alessandro Russo, Francesco Bandello, Rosangela Lattanzio
Investigative Ophthalmology Visual Science, 2025
Purpose: To characterize central bouquet hemorrhages (CBHs) in retinal vein occlusion (RVO) and evaluate their association with long-term visual and anatomical outcomes, in particular macular atrophy. This is a retrospective longitudinal cohort study of 403 treatment-naïve eyes with RVO (mean age, 62.9 ± 15.4 years; 59% male). Methods: CBH was identified on spectral-domain optical coherence tomography as vertically oriented light-absorbing masses centered at the fovea, above the external limiting membrane. Clinical characteristics, imaging findings, and intravitreal treatment frequency were compared between eyes with and without CBH. Baseline and longitudinal visual acuity analyzed with multivariable regression models, the prevalence of CBH-related features, and the cumulative incidence and predictors of macular atrophy assessed with Cox regression models were assessed. Results: CBH were observed in 28% of eyes (n = 111) at baseline. Affected eyes were older, had more systemic vascular comorbidities, and presented with more severe macular edema, peripapillary hemorrhages, and cotton-wool spots (all P < 0.001). Ischemic markers-including arteriolar paracentral acute middle maculopathy (P = 0.04) and increased ischemic index on fluorescein angiography (P = 0.02)-were more common in CBH eyes. Over time, CBH reabsorbed, often leaving a plaque-like RPE thickening, which progressed to outer retinal atrophy in 69% of cases over 36 months. Severe cystoid macular edema and full-thickness macular holes were also common. CBH was independently associated with worse baseline visual acuity (β = 0.09 logMAR; 95% confidence interval [CI], 0.01-0.18; P = 0.04) and slower visual recovery (β for CBH × Time = -0.002 logMAR/month; P < 0.001). Intravitreal treatments reduced the risk of macular atrophy (hazard ratio, 0.28; 95% CI, 0.08-0.96; P = 0.04), and each additional injection conferred a protective effect (hazard ratio, 0.96; 95% CI, 0.93-0.99; P = 0.02). Conclusions: CBH represents a characteristic hemorrhagic manifestation in RVO, likely reflecting the localized effects of elevated venous pressure and macular ischemia that contribute to structural disruption and poor visual outcomes. Its presence warrants close monitoring and sustained treatment to mitigate long-term retinal damage. - Lamina cribrosa perfusion density is reduced in eyes with central retinal vein occlusion
Matteo Menean, Lorenzo Bianco, Lida Perna, Gaia L’Abbate, Rosangela Lattanzio, Francesco Bandello, Luisa Pierro
Graefe S Archive for Clinical and Experimental Ophthalmology, 2025 - Diabetes-Driven Retinal Neurodegeneration: Its Role in the Pathogenesis of Diabetic Retinopathy
Ilaria Viganò, Silvia Galbiati, Emanuela Aragona, Daniela Gabellini, Rosangela Lattanzio, Vittoria Pedon, Giulia Basile, Alessandro Arrigo, Francesco Bandello, Gianpaolo Zerbini
Biomedicines, 2025
Diabetic retinopathy is a complication of diabetes characterized by an extremely low rate of progression. It takes several years to move from the onset of diabetes, both type 1 and type 2, to the development of retinal microaneurysms, then leading to proliferative diabetic retinopathy and vision loss. The recent demonstration that retinal microaneurysms are preceded and, possibly, caused by a subclinical neurodegeneration mainly affecting the neurovascular unit has suggested, on one hand, the possible existence of a previously unknown early neurodegenerative stage of diabetic retinopathy and, on the other, that an early “neuroprotective” treatment could end up preventing the development of the microvascular stages. This review summarizes the present situation in the field and focuses on the prevention of diabetic retinopathy, which seems, for the first time, to be within reach. - Vascular chorioretinal disorders
Sidra Zafar, Muhammad Ali, Lorenzo Maria Caminada, Beatrice Tombolini, Rosangela Lattanzio, et al.
Ultra Widefield Imaging of the Retina, 2025 - Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data
Francesco Boscia, Daniele Veritti, Cristiana Iaculli, Rosangela Lattanzio, Simona Freda, Benedetta Piergentili, Monica Varano
European Journal of Ophthalmology, 2024
The high prevalence of Diabetic macular edema (DME) is a real global health problem. Its complex pathophysiology involves different pathways. Over the last decade, the introduction of intravitreal treatments has dramatically changed the management and prognosis of DME. Among the different treatment options, inhibitors of vascular endothelial growth factor (anti-VEGF) and intravitreal steroids implants represent the first-line therapy of DME. We conducted a review of electronic databases to compile the available evidence about the clinical management of DME in a clinical setting, with a special focus on treatment-naïve patients. Anti-VEGF therapies represent a valuable option for treating DME patients. However, many patients do not respond properly to this treatment and, due to its administration regimen, many patients receive suboptimal treatment in real life. Current evidence demonstrated that in patients with DME, DEX-i improved significantly both anatomic and visual outcomes. Besides eyes with insufficient anti-VEGF respond or recalcitrant DME cases, DEX-i can be effectively and safely used in treatment-naïve DME patients as first line therapy. DEX-i may be considered first line therapy in different clinical scenarios, such as DME eyes with a greater inflammatory component, patients with cardiovascular events, vitrectomized eyes, or those requiring cataract surgery. In conclusion, there are still many points for improvement pending in the clinical management of the patient with DME. Since DME treatment must follow a patient-tailored approach, selecting the best therapeutic approach for each patient requires a good understanding of the pathophysiology of DME. - Real-world experience with fluocinolone acetonide intravitreal implant in patients with diabetic macular edema
Luigi Capone, Pietro Airaghi, Pasquale Aragona, Nicolò Castellino, Maria Vittoria Cicinelli, Francesco Ciucci, Michele Coppola, Cristiano De Gaetano, Rosangela Lattanzio, Massimo Lorusso, Martina Maceroni, Maria Elena Malvasi, Luisa Marco, Michele Marraffa, Gaia Martini, Rodolfo Mastropasqua, Angelo Maria Minnella, Eleni Nikolopulou, Elina Ortisi, Elena Pacella, Vincenzo Papa, Claudio Pennesi, Michele Reibaldi, Stanislao Rizzo, Lisa Toto, Luigi Trombetta, Francesco Bandello
European Journal of Ophthalmology, 2024 - Clinical characteristics and multimodal imaging findings in unilateral frosted branch angiitis: A case report
Giorgio Lari, Marco Battista, Alessandro Marchese, Alessandro Bordato, Rosangela Lattanzio, Giuseppe Querques, Giulio Modorati, Francesco Bandello, Elisabetta Miserocchi
Retinal Cases and Brief Reports, 2024 - Rate and Predictors of Misclassification of Active Diabetic Macular Edema as Detected by an Automated Retinal Image Analysis System
Lamberto La Franca, Carola Rutigliani, Lisa Checchin, Rosangela Lattanzio, Francesco Bandello, Maria Vittoria Cicinelli
Ophthalmology and Therapy, 2024 - Assessing Diabetic Retinopathy Staging With AI: A Comparative Analysis Between Pseudocolor and LED Imaging
Maria Vittoria Cicinelli, Salvatore Gravina, Carola Rutigliani, Lisa Checchin, Lamberto La Franca, Rosangela Lattanzio, Francesco Bandello
Translational Vision Science and Technology, 2024 - Validation of Esaso Classification of Diabetic Maculopathy
Giacomo Panozzo, Elia Franzolin, Diana Giannarelli, Giulia Dalla Mura, Rosa Longo, Maria Vittoria Cicinelli, Edoardo Angelini, Pietro Airaghi, Teresio Avitabile, Francesco Bandello, Andrea Beccastrini, Giorgia Benedetti, Federico Bertuzzi, Vincenza Maria Elena Bonfiglio, Francesco Boscia, Adriano Carnevali, Marianna Carosielli, Matteo Giuseppe Cereda, Cecilia Contardi, Michele Coppola, Ciro Costagliola, Riccardo Cristofolini, Pasquale Cucciniello, Rossella D’Aloisio, Maddalena De Bernardo, Alessandro De Filippis, Roberto Dell’Omo, Ilenia Di Paola, Matteo Dell’Acqua, Alessio Franco, Maria Oliva Grassi, Giulia Gregori, Elena Gusson, Rosangela Lattanzio, Paolo Lanzetta, Antonio Longo, Giorgio Marchini, Paola Marolo, Rodolfo Mastropasqua, Giuliana Mele Bertoldo, Giuseppina Monteleone, Elina Ortisi, Guglielmo Parisi, Salvatore Parrulli, Porzia Pucci, Marco Rocco Pastore, Michele Reibaldi, Stanislao Rizzo, Francesco Romano, Nicola Rosa, Valentina Sarao, Giuseppe Scarpa, Vincenzo Scorcia, Andrea Scupola, Giovanni Staurenghi, Valentina Sunseri Trapani, Daniele Tognetto, Giuseppe Trabucchi, Sabrina Vaccaro, Maria Vadalà, Daniele Veritti, Alex Lucia Vinciguerra, Emma Clara Zanzottera
European Journal of Ophthalmology, 2024 - From diagnosis to prognosis: A paradigm shift for multimodal imaging in assessing diabetic macular edema
Aurelio Apuzzo, Salvatore Gravina, Giacomo Panozzo, Rosangela Lattanzio, Maria Vittoria Cicinelli, Francesco Bandello
European Journal of Ophthalmology, 2024 - Rate and associations of inner retinal thinning in eyes with retinal vein occlusion and regressed macular oedema
Maria Vittoria Cicinelli, Lamberto La Franca, Alessandro Berni, Leonardo Bottazzi, Alessandro Rabiolo, Rosangela Lattanzio, Patricia Udaondo, Francesco Bandello
Eye Basingstoke, 2024 - Imaging Biomarkers of Mesopic and Dark-Adapted Macular Functions in Eyes With Treatment-Naïve Mild Diabetic Retinopathy
Francesco Bandello, Enrico Borrelli, Marco Trevisi, Rosangela Lattanzio, Riccardo Sacconi, Giuseppe Querques
American Journal of Ophthalmology, 2023 - Associations and Prognostic Significance of Fluctuations in Diabetic Retinopathy Severity in Eyes Treated for Diabetic Macular Edema
Maria Vittoria Cicinelli, Giulia Gregori, Alessandro Rabiolo, Beatrice Tombolini, Costanza Barresi, Francesco Pignatelli, Rosangela Lattanzio, Francesco Bandello
Ophthalmologica, 2023 - Factors associated with the response to fluocinolone acetonide 0.19 mg in diabetic macular oedema evaluated as the area-under-the-curve
Maria Vittoria Cicinelli, Alessandro Rabiolo, Luigi Capone, Carlo Di Biase, Rosangela Lattanzio, Francesco Bandello
Eye Basingstoke, 2023 - Foveal eversion patterns in diabetic macular edema
Alessandro Arrigo, Andrea Saladino, Emanuela Aragona, Alessia Amato, Luigi Capone, Lorenzo Bianco, Rosangela Lattanzio, Francesco Bandello, Maurizio Battaglia Parodi
Scientific Reports, 2022 - Multidisciplinary management of patients diagnosed with von Hippel-Lindau disease: A practical review of the literature for clinicians
Alessandro Larcher, Federico Belladelli, Giuseppe Fallara, Isaline Rowe, Umberto Capitanio, Laura Marandino, Daniele Raggi, Jody Filippo Capitanio, Michele Bailo, Rosangela Lattanzio, Costanza Barresi, Sonia Francesca Calloni, Maurizio Barbera, Valentina Andreasi, Giorgia Guazzarotti, Giovanni Pipitone, Paola Carrera, Andrea Necchi, Pietro Mortini, Francesco Bandello, Andrea Falini, Stefano Partelli, Massimo Falconi, Francesco De Cobelli, Andrea Salonia
Asian Journal of Urology, 2022 - The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience
Edoardo Midena, Chiara Polo, Luisa Frizziero, Maria Giulia Marini, Rosangela Lattanzio, Maria Vadalà, Elisabetta Pilotto, Monica Varano
International Journal of Environmental Research and Public Health, 2022 - Epiretinal Membrane Peeling in Eyes with Retinal Vein Occlusion: Visual and Morphologic Outcomes
Maria Vittoria Cicinelli, Irini Chatziralli, Sara Touhami, Anissa Smaoui, Beatrice Tombolini, Marco Nassisi, Panagiotis Theodossiadis, Rosangela Lattanzio, Francesco Bandello
Ophthalmology and Therapy, 2022 - Assessment of Diabetic Choroidopathy Using Ultra-Widefield Optical Coherence Tomography
Nicolò Nicolini, Beatrice Tombolini, Costanza Barresi, Francesco Pignatelli, Rosangela Lattanzio, Francesco Bandello, Maria Vittoria Cicinelli
Translational Vision Science and Technology, 2022 - Correction: The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema (Eye, (2021), 35, 12, (3232-3242), 10.1038/s41433-020-01373-1)
Maria Vittoria Cicinelli, Amir Rosenblatt, Domenico Grosso, Piero Zollet, Luigi Capone, Alessandro Rabiolo, Rosangela Lattanzio, Anat Loewenstein, Francesco Bandello, and
Eye Basingstoke, 2021 - The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema
Maria Vittoria Cicinelli, Amir Rosenblatt, Domenico Grosso, Piero Zollet, Luigi Capone, Alessandro Rabiolo, Rosangela Lattanzio, Anat Loewenstein, Francesco Bandello, Marco Nassisi, Anna Tan, Rhianon Reynolds, Sumit Randhir Singh, Kaivon P. Vaezi, Audrey Giocanti-Aurégan, Tamir Weinberg, Livia Faes, Roy Schwartz, Denis Yurani Anaya Reyes, Alfonso Savastano, Sara Touhami, Humberto Ruiz Garcia, Dominika Pohlmann, Adam Plant, Camila V. Ventura, Irini Chatziralli, Nopasak Phasukkijwatana, Jorge Ruiz-Medrano, Miner Yuan, İhsan Yılmaz, Denise Vogt, Daniel Shu Wei Ting, Mushawiahti Mustapha, Marcos Mendaro, and
Eye Basingstoke, 2021 - Collateral vessel development in central and branch retinal vein occlusions are associated with worse visual and anatomic outcomes
Alessandro Arrigo, Emanuela Aragona, Rosangela Lattanzio, Giovanni Scalia, Francesco Bandello, Maurizio Battaglia Parodi
Investigative Ophthalmology and Visual Science, 2021 - Real-Life Management of Central and Branch Retinal Vein Occlusion: A Seven-Year Follow-Up Study
Alessandro Arrigo, Anna Crepaldi, Chiara Viganò, Emanuela Aragona, Rosangela Lattanzio, Giovanni Scalia, Antonio Giordano Resti, Francesca Calcagno, Adelaide Pina, Hassan Farah Rashid, Francesco Bandello, Maurizio Battaglia Parodi
Thrombosis and Haemostasis, 2021 - Intraocular Pressure Changes Are Predictive of Ocular Hypertension Onset After Fluocinolone Acetonide Implant: Significant Cutoffs and the Role of Previous DEX Implant
Alessandro Arrigo, Emanuela Aragona, Luigi Capone, Carlo Di Biase, Rosangela Lattanzio, Francesco Bandello
Frontiers in Medicine, 2021 - Foveal Eversion: A Possible Biomarker of Persistent Diabetic Macular Edema
Alessandro Arrigo, Emanuela Aragona, Luigi Capone, Rosangela Lattanzio, Piero Zollet, Francesco Bandello
Ophthalmology and Therapy, 2021 - The role of inflammation and neurodegeneration in diabetic macular edema
Vincenzo Starace, Marco Battista, Maria Brambati, Michele Cavalleri, Federico Bertuzzi, Alessia Amato, Rosangela Lattanzio, Francesco Bandello, Maria Vittoria Cicinelli
Therapeutic Advances in Ophthalmology, 2021 - Optical Coherence Tomography Biomarkers of Inflammation in Diabetic Macular Edema Treated by Fluocinolone Acetonide Intravitreal Drug-Delivery System Implant
Alessandro Arrigo, Luigi Capone, Rosangela Lattanzio, Emanuela Aragona, Piero Zollet, Francesco Bandello
Ophthalmology and Therapy, 2020 - Cataract surgery with combined versus deferred intravitreal dexamethasone implant for diabetic macular edema: long-term outcomes from a real-world setting
Eleonora Corbelli, Francesco Fasce, Lorenzo Iuliano, Riccardo Sacconi, Rosangela Lattanzio, Francesco Bandello, Giuseppe Querques
Acta Diabetologica, 2020 - Nonmydriatic widefield retinal imaging with an automatic white LED confocal imaging system compared with dilated ophthalmoscopy in screening for diabetic retinopathy
Enrico Borrelli, Lea Querques, Rosangela Lattanzio, Michele Cavalleri, Alessio Grazioli Moretti, Carlo Di Biase, Alberto Signorino, Francesco Gelormini, Riccardo Sacconi, Francesco Bandello, Giuseppe Querques
Acta Diabetologica, 2020 - Retinal Arteriovenous Malformation Occlusion and Optic Nerve Drusen: Casuality or Causality?
Marco Battista, Maria Vittoria Cicinelli, Rosangela Lattanzio, Francesco Bandello
Ophthalmic Surgery Lasers and Imaging Retina, 2020 - Persistent or Recurrent Diabetic Macular Edema After Fluocinolone Acetonide 0.19 mg Implant: Risk Factors and Management
Maria Vittoria Cicinelli, Alessandro Rabiolo, Piero Zollet, Luigi Capone, Rosangela Lattanzio, Francesco Bandello
American Journal of Ophthalmology, 2020 - Proliferative diabetic retinopathy as onset of type 1 diabetes
Antonio Basurto, Maria Vittoria Cicinelli, Rosangela Lattanzio, Francesco Bandello
Canadian Journal of Ophthalmology, 2020 - The usefulness of serum biomarkers in the early stages of diabetic retinopathy: Results of the EUROCONDOR clinical trial
Cristina Hernández, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon P. Harding, Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, José Cunha-Vaz, Rafael Simó
Journal of Clinical Medicine, 2020 - Purtscher-like features in new-onset diabetic retinopathy
Marco Battista, Maria Vittoria Cicinelli, Vincenzo Starace, Rosangela Lattanzio, Francesco Bandello
Acta Diabetologica, 2020 - The current role of steroids in diabetic macular edema
Maria Vittoria Cicinelli, Michele Cavalleri, Rosangela Lattanzio, Francesco Bandello
Expert Review of Ophthalmology, 2020 - Diabetic retinopathy - clinical
Francesco Bandello, Rosangela Lattanzio, Alessandro Marchese, Emanuela Aragona
Microvascular Disease in Diabetes, 2020 - Vision-related quality of life and locus of control in type 1 diabetes: a multicenter observational study
Marina Trento, Lorena Charrier, Franco Cavallo, Stefania Bertello, Salvatore Oleandri, Maria Carla Donati, Salvatore Rizzo, Gianni Virgili, Giuseppe Picca, Francesco Bandello, Rosangela Lattanzio, Elena Aragona, Roberto Perilli, Stefano Casati, Elena Beltramo, Aurora Mazzeo, Paolo Fornengo, Olga Durando, Stefano Merlo, Massimo Porta
Acta Diabetologica, 2019 - New imaging systems in diabetic retinopathy
Maria Vittoria Cicinelli, Michele Cavalleri, Maria Brambati, Rosangela Lattanzio, Francesco Bandello
Acta Diabetologica, 2019 - Effects of topically administered neuroprotective drugs in early stages of diabetic retinopathy: Results of the EUROCONDOR clinical trial
Rafael Simó, Cristina Hernández, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon P. Harding, Stephen J. Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E. Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Scanlon, Conceição Lobo, Miguel Ângelo Costa, José Cunha-Vaz
Diabetes, 2019 - Preface
Clinical Strategies in the Management of Diabetic Retinopathy A Step by Step Guide for Ophthalmologists Second Edition, 2018 - Clinical Strategies in the Management of Diabetic Retinopathy: A Step-by-Step Guide for Ophthalmologists, Second Edition
Francesco Bandello, Marco A. Zarbin, Rosangela Lattanzio, Ilaria Zucchiatti
Clinical Strategies in the Management of Diabetic Retinopathy A Step by Step Guide for Ophthalmologists Second Edition, 2018 - Proliferative Diabetic Retinopathy
Francesco Bandello, Lorenzo Iuliano, Giovanni Fogliato, Ilaria Zucchiatti, Rosangela Lattanzio, Gisella Maestranzi
Clinical Strategies in the Management of Diabetic Retinopathy A Step by Step Guide for Ophthalmologists Second Edition, 2018 - Diabetic Macular Edema
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti, Alessandro Arrigo, Marco Battista, Maria Vittoria Cicinelli
Clinical Strategies in the Management of Diabetic Retinopathy A Step by Step Guide for Ophthalmologists Second Edition, 2018 - Nonproliferative Diabetic Retinopathy
Francesco Bandello, Rosangela Lattanzio, Emanuela Aragona, Alessandro Marchese, Giuseppe Querques, Ilaria Zucchiatti
Clinical Strategies in the Management of Diabetic Retinopathy A Step by Step Guide for Ophthalmologists Second Edition, 2018 - Correlation Analysis between Foveal Avascular Zone and Peripheral Ischemic Index in Diabetic Retinopathy: A Pilot Study
Alessandro Rabiolo, Maria Vittoria Cicinelli, Eleonora Corbelli, Giovanni Baldin, Adriano Carnevali, Rosangela Lattanzio, Lea Querques, Francesco Bandello, Giuseppe Querques
Ophthalmology Retina, 2018 - Widefield OCT Angiography of Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis
Alessandro Marchese, Elisabetta Miserocchi, Giulio Modorati, Alessandro Rabiolo, Erika Poggiali, Rosangela Lattanzio, Luigi De Vitis, Lea Querques, Giuseppe Querques, Francesco Bandello
Ophthalmology Retina, 2017 - Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity
Riccardo Sacconi, Maurizio Battaglia Parodi, Stefano Casati, Rosangela Lattanzio, Giorgio Marchini, Francesco Bandello
Ophthalmic Research, 2017 - Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: Cross-sectional analyses of baseline data of the EUROCONDOR project
Ana Rita Santos, Luísa Ribeiro, Francesco Bandello, Rosangela Lattanzio, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Jakob Grauslund, Simon P. Harding, Gabriele E. Lang, Pascale Massin, Edoardo Midena, Peter Scanlon, Stephen J. Aldington, Sílvia Simão, Christian Schwartz, Berta Ponsati, Massimo Porta, Miguel Ângelo Costa, Cristina Hernández, José Cunha-Vaz, Rafael Simó
Diabetes, 2017 - Preface
F. Bandello, Marco A. Zarbin, Rosangela Lattanzio, Ilaria Zucchiatti, Mizpah Publishing Service, et al.
Developments in Ophthalmology, 2017 - Sudden visual loss after cardiac resynchronization therapy device implantation
Luigi A. De Vitis, Alessandro Marchese, Chiara Giuffrè, Adriano Carnevali, Lea Querques, Livia Tomasso, Giovanni Baldin, Gisella Maestranzi, Rosangela Lattanzio, Giuseppe Querques, Francesco Bandello
European Journal of Ophthalmology, 2017 - Intravitreal Steroids in Diabetic Macular Edema
Rosangela Lattanzio, Maria Vittoria Cicinelli, Francesco Bandello
Developments in Ophthalmology, 2017 - Optical coherence tomography angiography findings in laser maculopathy
Livia Tomasso, Lucia Benatti, Carlo La Spina, Rosangela Lattanzio, Giovanni Baldin, Adriano Carnevali, Luigi A. De Vitis, Lea Querques, Francesco Bandello, Giuseppe Querques
European Journal of Ophthalmology, 2017 - Diagnostic and Therapeutic Challenges
Federico Corvi, Rosangela Lattanzio, Elisabetta Miserocchi, Lea Querques, Francesco Bandello, Giuseppe Querques, Daniel E. Croft, Charles C. Wykoff
Retina, 2016 - Optical Coherence Tomography Angiography in Dystrophies
Maurizio Battaglia Parodi, Luisa Pierro, Marco Gagliardi, Rosangela Lattanzio, Giuseppe Querques, Francesco Bandello
Developments in Ophthalmology, 2016 - Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: Subgroup analysis of the MEAD study
for the Ozurdex MEAD Study Group, Albert J. Augustin, Baruch D. Kuppermann, Paolo Lanzetta, Anat Loewenstein, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M. Whitcup
BMC Ophthalmology, 2015 - Dynamic and static retinal vessel analyses in patients with macular edema secondary to retinal vein occlusion
Federico Corvi, Giuseppe Querques, Carlo La Spina, Rosangela Lattanzio, Francesco Bandello
Retina, 2015 - Impact of intravitreal ranibizumab on vessel functionality in patients with retinal vein occlusion
Federico Corvi, Carlo La Spina, Lucia Benatti, Lea Querques, Rosangela Lattanzio, Francesco Bandello, Giuseppe Querques
American Journal of Ophthalmology, 2015 - Repeated intravitreal dexamethasone implant (ozurdex) for diabetic macular EDEMA
Matteo Scaramuzzi, Giuseppe Querques, Carlo La Spina, Rosangela Lattanzio, Francesco Bandello
Retina, 2015 - Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion
Francesco Bandello, Mariacristina Parravano, Edoardo Cavallero, Maria Lucia Cascavilla, Giacinto Triolo, Lea Querques, Enrico Borrelli, Paola Giorno, Monica Varano, Rosangela Lattanzio, Giuseppe Querques
Ophthalmic Research, 2015 - Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse
Silvia Maestroni, Anna Maestroni, Simona Ceglia, Gemma Tremolada, Monica Mancino, Angelina Sacchi, Rosangela Lattanzio, Ilaria Zucchiatti, Angelo Corti, Francesco Bandello, Gianpaolo Zerbini
Acta Ophthalmologica, 2015 - Optical coherence tomographic hyperreflective foci in early stages of diabetic retinopathy
Umberto De Benedetto, Riccardo Sacconi, Luisa Pierro, Rosangela Lattanzio, Francesco Bandello
Retina, 2015 - Macular dysfunction is common in both type 1 and type 2 diabetic patients without macular edema
Umberto De Benedetto, Giuseppe Querques, Rosangela Lattanzio, Enrico Borrelli, Giacinto Triolo, Gisella Maestranzi, Giliola Calori, Lea Querques, Francesco Bandello
Retina, 2014 - A case of branch retinal artery occlusion following orbital cavernous hemangioma excision
Riccardo Sacconi, Antonio Giordano Resti, Rosangela Lattanzio, Luisa Pierro, Armando D'angelo, Nicola Baccelli, Francesco Bandello
European Journal of Ophthalmology, 2014 - Update of intravitreal steroids for the treatment of diabetic macular edema
Francesco Bandello, Chiara Preziosa, Giuseppe Querques, Rosangela Lattanzio
Ophthalmic Research, 2014 - Natural course of photic maculopathy secondary to uncomplicated cataract surgery
Lea Querques, Giuseppe Querques, Maria Lucia Cascavilla, Giacinto Triolo, Rosangela Lattanzio, Ugo Introini, Francesco Bandello
Clinical and Experimental Optometry, 2014 - Enhanced depth imaging optical coherence tomography findings associated with serous retinal detachment in preeclampsia
Lea Querques, Giuseppe Querques, Francesco Loperfido, Rosangela Lattanzio, Francesco Bandello
Archives of Gynecology and Obstetrics, 2014 - Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function
Giuseppe Querques, Rosangela Lattanzio, Lea Querques, Giacinto Triolo, Maria L. Cascavilla, Edoardo Cavallero, Claudia Del Turco, Giuseppe Casalino, Francesco Bandello
Retina, 2014 - Central retinal vein occlusion in a young patient following cannabis smoke inhalation
Federico Corvi, Giuseppe Querques, Rosangela Lattanzio, Chiara Preziosa, Maurizio Battaglia Parodi, Francesco Bandello
European Journal of Ophthalmology, 2014 - Natural history of premacular hemorrhage due to severe acute anemia: Clinical and anatomical features in two untreated patients
Claudia Del Turco, Carlo La Spina, Elena Mantovani, Marco Gagliardi, Rosangela Lattanzio, Luisa Pierro
Ophthalmic Surgery Lasers and Imaging Retina, 2014 - Dexamethasone tachyphylaxis in the treatment of macular oedema
Maurizio Battaglia Parodi, Pierluigi Iacono, Claudio Campa, Carlo La Spina, Giacinto Triolo, Rosangela Lattanzio, Francesco Bandello
Acta Ophthalmologica, 2014 - Changes in macular function after Ozurdex for retinal vein occlusion
Giuseppe Querques, Maria Lucia Cascavilla, Edoardo Cavallero, Giacinto Triolo, Lea Querques, Rosangela Lattanzio, Maria Vittoria Cicinelli, Chiara Preziosa, Enrico Borrelli, Francesco Bandello
Optometry and Vision Science, 2014 - Correspondence
Giuseppe Querques, Rosangela Lattanzio, Francesco Bandello
Retina, 2013 - Pathophysiology and treatment of diabetic retinopathy
Francesco Bandello, Rosangela Lattanzio, Ilaria Zucchiatti, Claudia Del Turco
Acta Diabetologica, 2013 - Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion
Umberto De Benedetto, Maurizio Battaglia Parodi, Karl Anders Knutsson, Rosangela Lattanzio, Francesco Bandello, Pierluigi Iacono
Acta Ophthalmologica, 2013 - Diagnostic and therapeutic challenges
Giuseppe Querques, Rosangela Lattanzio, Lea Querques, Francesco Bandello, K. Bailey Freund
Retina, 2013 - Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion
Lea Querques, Giuseppe Querques, Rosangela Lattanzio, Silvia Rita Gigante, Claudia Del Turco, Giulia Corradetti, Maria Lucia Cascavilla, Francesco Bandello
Ophthalmologica, 2012 - Enhanced depth imaging optical coherence tomography in type 2 diabetes
Giuseppe Querques, Rosangela Lattanzio, Lea Querques, Claudia Del Turco, Raimondo Forte, Luisa Pierro, Eric H. Souied, Francesco Bandello
Investigative Ophthalmology and Visual Science, 2012 - Proliferative diabetic retinopathy: Laser treatment and intravitreal medication
Surgical Retina, 2012 - Primitive retinal vascular abnormalities: Tumors and telangiectasias
Karl Anders Knutsson, Umberto De Benedetto, Giuseppe Querques, Claudia Del Turco, Francesco Bandello, Rosangela Lattanzio
Ophthalmologica, 2012 - Intravitreal dexamethasone implant in patients with persistent diabetic macular edema
Ilaria Zucchiatti, Rosangela Lattanzio, Giuseppe Querques, Lea Querques, Claudia Del Turco, Maria Lucia Cascavilla, Francesco Bandello
Ophthalmologica, 2012 - The role of angiogenesis in the development of proliferative diabetic retinopathy: Impact of intravitreal anti-VEGF treatment
Gemma Tremolada, Claudia Del Turco, Rosangela Lattanzio, Silvia Maestroni, Anna Maestroni, Francesco Bandello, Gianpaolo Zerbini
Experimental Diabetes Research, 2012 - Endothelial progenitor cells carrying monocyte markers are selectively abnormal in type 1 diabetic patients with early retinopathy
Gianpaolo Zerbini, Anna Maestroni, Alessio Palini, Gemma Tremolada, Rosangela Lattanzio, Silvia Maestroni, Matteo Rocco Pastore, Antonio Secchi, Riccardo Bonfanti, Chiara Gerhardinger, Mara Lorenzi
Diabetes, 2012 - Macular micropseudocysts in early stages of diabetic retinopathy
Gemma Tremolada, Luisa Pierro, Umberto de Benedetto, Sergio Margari, Marco Gagliardi, Gisella Maestranzi, Giliola Calori, Mara Lorenzi, Rosangela Lattanzio
Retina, 2011 - Retinal vein occlusion: Current treatment
Rosangela Lattanzio, Ana Torres Gimeno, Maurizio Battaglia Parodi, Francesco Bandello
Ophthalmologica, 2011 - Steroids as part of combination treatment: The future for the management of macular edema?
F. Bandello, M. Battaglia Parodi, G. Tremolada, R. Lattanzio, U. De Benedetto, P. Iacono
Ophthalmologica, 2010 - The therapeutic potential of VEGF inhibition in diabetic microvascular complications
Gemma Tremolada, Rosangela Lattanzio, Gabriella Mazzolari, Gianpaolo Zerbini
American Journal of Cardiovascular Drugs, 2007 - Macular hole and intravitreal injection of triamcinolone acetonide for macular edema due to central retinal vein occlusion
R. Lattanzio, A. Ramoni, F. Scotti, U. Introini
European Journal of Ophthalmology, 2007 - Perception of, and anxiety levels induced by, laser treatment in patients with sight-threatening diabetic retinopathy. A multicentre study
M. Trento, M. Tomelini, R. Lattanzio, R. Brancato, A. Coggiola, R. Benecchi, L. Scoccianti, C. Insacco, F. Bandello, M. Montanaro, F. Cavallo, M. Porta
Diabetic Medicine, 2006 - Increased clonogenic potential of circulating endothelial progenitor cells in patients with type 1 diabetes and proliferative retinopathy [2]
V. Asnaghi, R. Lattanzio, G. Mazzolari, M. R. Pastore, A. Ramoni, A. Maestroni, D. Ruggieri, L. Luzi, R. Brancato, G. Zerbini
Diabetologia, 2006 - Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion
ROSANGELA LATTANZIO, FRANCESCA SAMPIETRO, ANDREA RAMONI, ANNALISA FATTORINI, ROSARIO BRANCATO, ARMANDO DʼANGELO
Retina, 2006 - Macular thickness measured by optical coherence tomography (OCT) in diabetic patients
R. Lattanzio, R. Brancato, L. Pierro, F. Bandello, B. Iaccheri, T. Fiore, G. Maestranzi
European Journal of Ophthalmology, 2002 - Florid diabetic retinopathy (FDR): A long-term follow-up study
Rosangela Lattanzio, Rosario Brancato, Francesco M. Bandello, Claudio Azzolini, Angela Malegori, Gisella Maestranzi
Graefe S Archive for Clinical and Experimental Ophthalmology, 2001 - Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
Nish Chaturvedi, Simona Bandinelli, Ruggero Mangili, Guiseppe Penno, Raoul E. Rottiers, John H. Fuller
Kidney International, 2001 - Assessment of severity is an important tool in the treatment of acute biliary pancreatitis
Minerva Chirurgica, 2000 - The management of acute biliary pancreatitis in older patients in the endolaparoscopic era
Minerva Chirurgica, 1999 - Axial length in patients with diabetes
LUISA PIERRO, ROSARIO BRANCATO, XAVIER ROBINO, ROSANGELA LATTANZIO, ANNA JANSEN, GILIOLA CALORI
Retina, 1999 - Markers of insulin resistance are associated with cardiovascular morbidity and predict overall mortality in long-standing non-insulin-dependent diabetes mellitus
A. E. Pontiroli, M. Pacchioni, R. Camisasca, R. Lattanzio
Acta Diabetologica, 1998 - High-frequency ultrasound biomicroscopy versus ultrasound and optical pachymetry for the measurement of corneal thickness
Luisa Pierro, Eugenio Conforto, Antonio Giordano Resti, Rosangela Lattanzio
Ophthalmologica, 1998 - Iris fluorescein angiography in clinical practice
Rosario Brancato, Francesco Bandello, Rosangela Lattanzio
Survey of Ophthalmology, 1997 - Double-frequency Nd:YAG laser vs. argon-green laser in the treatment of proliferative diabetic retinopathy: Randomized study with long-term follow- up
Francesco Bandello, Rosario Brancato, Rosangela Lattanzio, Giuseppe Trabucchi, Claudio Azzolini, Angela Malegori
Lasers in Surgery and Medicine, 1996 - Diabetic Papillopathy (DP): A 4-year follow-up study of 69 eyes
Investigative Ophthalmology and Visual Science, 1996 - Diabetic patients with retinopathy present shorter axial length
Investigative Ophthalmology and Visual Science, 1996 - Florid diabetic retinopathy: A long-term follow-up study
Investigative Ophthalmology and Visual Science, 1996 - Spontaneous regression of neovascularization at the disk and elsewhere in diabetic retinopathy
FRANCESCO BANDELLO, J. DONALD M. GASS, ROSANGELA LATTANZIO, ROSARIO BRANCATO
American Journal of Ophthalmology, 1996 - Acute biliary pancreatitis: mini-invasive treatment
Chirurgia Italiana, 1996 - Bovine factor VIII derivative in the treatment of non-proliferative diabetic retinopathy
Francesco Bandello, Rosangela Lattanzio, Gisella Maestranzi, Rosario Brancato
Ophthalmologica, 1995 - Biomicroscopy and fluorescein angiography of pigmented iris tumors - A retrospective study on 44 cases
Francesco Bandello, Rosario Brancato, Rosangela Lattanzio, Alfonso Carnevalini, Antonio Rossi, Gabriel Coscas
International Ophthalmology, 1994 - Relation between iridopathy and retinopathy in diabetes
F Bandello, R Brancato, R Lattanzio, M Galdini, B Falcomata
British Journal of Ophthalmology, 1994 - Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: A randomized study in 44 eyes with a long follow-up time
Francesco Bandello, Rosario Brancato, Giuseppe Trabuccbi, Rosangela Lattanzio, Angela Malegori
Graefe S Archive for Clinical and Experimental Ophthalmology, 1993 - Biomicroscopy versus fluorescein angiography of the iris in the detection of diabetic iridopathy
Francesco Bandello, Rosario Brancato, Rosangela Lattanzio, Bruno Falcomatà, Angela Malegori
Graefe S Archive for Clinical and Experimental Ophthalmology, 1993 - Laser treatment of iris vascular tufts
Francesco Bandello, Rosario Brancato, Rosangela Lattanzio, Gisella Maestranzi
Ophthalmologica, 1993 - Frequency-doubled Nd:YAG laser versus argon-green laser photocoagulation in proliferative diabetic retinopathy: A preliminary report
Lasers and Light in Ophthalmology, 1991 - The atypical forms of diabetic retinopathy
Annali Di Ottalmologia E Clinica Oculistica, 1990 - Diabetic choroidopathy: A fluorangiographic study
Annali Di Ottalmologia E Clinica Oculistica, 1990 - Retinal fluorescein angiography in diagnosis of choroidal melanoma: a 36 case retrospective study
Annali Di Ottalmologia E Clinica Oculistica, 1990 - Argon and diode laser photocoagulation in proliferative diabetic retinopathy: A preliminary report
Lasers and Light in Ophthalmology, 1990 - The endoscopic diagnosis of rectorrhagias
Annali Italiani Di Chirurgia, 1990
